GB Meka
Stocks to watch

RCKT

Compare

ROCKET PHARMACEUTICALS INC · Healthcare

$2.67
▲ 3.3%Close 2026-09-30

Live intraday price

Compare with our price levels

T23.65
T13.39
E12.36
E31.66
SL1.43

Close 2026-09-30: $2.67 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▲ Leaning positive

Not in the buy zone yet — needs to drop 11.8% · 1 whale recently bought

1 month
▼ 28.1%
3 months
▼ 24.0%
1 year
▼ 18.4%
Analyst target
$8.85 +231.0%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$2.36 -11.8%
E2$2.01 -24.8%
E3$1.66 -37.8%
Targets
T1$3.39 26.6%
T2$3.65 36.6%
T3$4.03 50.8%
Stop-loss
SL$1.43 -46.5%
Whale cost ~$4.08 52.4%

Risk : reward 1 : 2.8Moves ~$0.23 a day

⚖️ Positives and risks

✓ Positives (3)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 8.85 (upside +231%, 12 ราย)
  • ●นักวิเคราะห์ส่วนใหญ่แนะนำ Buy
! Risks (1)
  • ●อ่อนแอกว่าตลาด (S&P 500) -44% ใน 6 เดือน

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$284M
Next earnings2026-11-05
P/E (price to earnings)-
Forward P/E (on expected earnings)-2.0
Revenue growth (YoY)-
Earnings growth (YoY)-
Net profit margin0.0%
ROE-4.8%
Debt to equity (D/E)7%
Dividend yield-
Analyst targets (high / low)$15.00 / $3.00
Number of analysts12
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Downtrend ↘ · Sideways →
RSI31
MA50 / MA200$3.39 / $3.57
Distance from MA200-25.2%
MACDNegative
1-year high / low$5.45 / $2.51
vs. S&P 500 (6 months)-44.0%
Volume vs. average0.35×